Global Cell Therapy CDMO Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Cell Therapy CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cell Therapy CDMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cell Therapy CDMO market in any manner.
Global Cell Therapy CDMO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Charles River
The Discovery Labs
BIOCENTRIQ
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith
ThermoGenesis
Anemocyte
Thermo Fisher Scientific
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio
Market Segmentation (by Type)
Stem Cell
Non-Stem Cell
Market Segmentation (by Application)
Commercial
Academic Research
Others
Geographic Segmentation
%li%North America (USA, Canada, Mexico)
%li%Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
%li%Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
%li%South America (Brazil, Argentina, Columbia, Rest of South America)
%li%The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
%li%Industry drivers, restraints, and opportunities covered in the study
%li%Neutral perspective on the market performance
%li%Recent industry trends and developments
%li%Competitive landscape & strategies of key players
%li%Potential & niche segments and regions exhibiting promising growth covered
%li%Historical, current, and projected market size, in terms of value
%li%In-depth analysis of the Cell Therapy CDMO Market
%li%Overview of the regional outlook of the Cell Therapy CDMO Market:
Key Reasons to Buy this Report:
%li%Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
%li%This enables you to anticipate market changes to remain ahead of your competitors
%li%You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
%li%The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
%li%Provision of market value (USD Billion) data for each segment and sub-segment
%li%Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
%li%Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
%li%Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
%li%Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
%li%The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
%li%Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
%li%Provides insight into the market through Value Chain
%li%Market dynamics scenario, along with growth opportunities of the market in the years to come
%li%6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell Therapy CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Cell Therapy CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cell Therapy CDMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cell Therapy CDMO market in any manner.
Global Cell Therapy CDMO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Charles River
The Discovery Labs
BIOCENTRIQ
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith
ThermoGenesis
Anemocyte
Thermo Fisher Scientific
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio
Market Segmentation (by Type)
Stem Cell
Non-Stem Cell
Market Segmentation (by Application)
Commercial
Academic Research
Others
Geographic Segmentation
%li%North America (USA, Canada, Mexico)
%li%Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
%li%Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
%li%South America (Brazil, Argentina, Columbia, Rest of South America)
%li%The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
%li%Industry drivers, restraints, and opportunities covered in the study
%li%Neutral perspective on the market performance
%li%Recent industry trends and developments
%li%Competitive landscape & strategies of key players
%li%Potential & niche segments and regions exhibiting promising growth covered
%li%Historical, current, and projected market size, in terms of value
%li%In-depth analysis of the Cell Therapy CDMO Market
%li%Overview of the regional outlook of the Cell Therapy CDMO Market:
Key Reasons to Buy this Report:
%li%Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
%li%This enables you to anticipate market changes to remain ahead of your competitors
%li%You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
%li%The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
%li%Provision of market value (USD Billion) data for each segment and sub-segment
%li%Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
%li%Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
%li%Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
%li%Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
%li%The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
%li%Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
%li%Provides insight into the market through Value Chain
%li%Market dynamics scenario, along with growth opportunities of the market in the years to come
%li%6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell Therapy CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cell Therapy CDMO
1.2 Key Market Segments
1.2.1 Cell Therapy CDMO Segment by Type
1.2.2 Cell Therapy CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL THERAPY CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL THERAPY CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Global Cell Therapy CDMO Revenue Market Share by Company (2019-2024)
3.2 Cell Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Cell Therapy CDMO Market Size Sites, Area Served, Product Type
3.4 Cell Therapy CDMO Market Competitive Situation and Trends
3.4.1 Cell Therapy CDMO Market Concentration Rate
3.4.2 Global 5 and 10 Largest Cell Therapy CDMO Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 CELL THERAPY CDMO VALUE CHAIN ANALYSIS
4.1 Cell Therapy CDMO Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL THERAPY CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 CELL THERAPY CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell Therapy CDMO Market Size Market Share by Type (2019-2024)
6.3 Global Cell Therapy CDMO Market Size Growth Rate by Type (2019-2024)
7 CELL THERAPY CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell Therapy CDMO Market Size (M USD) by Application (2019-2024)
7.3 Global Cell Therapy CDMO Market Size Growth Rate by Application (2019-2024)
8 CELL THERAPY CDMO MARKET SEGMENTATION BY REGION
8.1 Global Cell Therapy CDMO Market Size by Region
8.1.1 Global Cell Therapy CDMO Market Size by Region
8.1.2 Global Cell Therapy CDMO Market Size Market Share by Region
8.2 North America
8.2.1 North America Cell Therapy CDMO Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cell Therapy CDMO Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cell Therapy CDMO Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cell Therapy CDMO Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cell Therapy CDMO Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Charles River
9.1.1 Charles River Cell Therapy CDMO Basic Information
9.1.2 Charles River Cell Therapy CDMO Product Overview
9.1.3 Charles River Cell Therapy CDMO Product Market Performance
9.1.4 Charles River Cell Therapy CDMO SWOT Analysis
9.1.5 Charles River Business Overview
9.1.6 Charles River Recent Developments
9.2 The Discovery Labs
9.2.1 The Discovery Labs Cell Therapy CDMO Basic Information
9.2.2 The Discovery Labs Cell Therapy CDMO Product Overview
9.2.3 The Discovery Labs Cell Therapy CDMO Product Market Performance
9.2.4 The Discovery Labs Cell Therapy CDMO SWOT Analysis
9.2.5 The Discovery Labs Business Overview
9.2.6 The Discovery Labs Recent Developments
9.3 BIOCENTRIQ
9.3.1 BIOCENTRIQ Cell Therapy CDMO Basic Information
9.3.2 BIOCENTRIQ Cell Therapy CDMO Product Overview
9.3.3 BIOCENTRIQ Cell Therapy CDMO Product Market Performance
9.3.4 BIOCENTRIQ Cell Therapy CDMO SWOT Analysis
9.3.5 BIOCENTRIQ Business Overview
9.3.6 BIOCENTRIQ Recent Developments
9.4 FUJIFILM Diosynth Biotechnologies
9.4.1 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Basic Information
9.4.2 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product Overview
9.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product Market Performance
9.4.4 FUJIFILM Diosynth Biotechnologies Business Overview
9.4.5 FUJIFILM Diosynth Biotechnologies Recent Developments
9.5 Exothera
9.5.1 Exothera Cell Therapy CDMO Basic Information
9.5.2 Exothera Cell Therapy CDMO Product Overview
9.5.3 Exothera Cell Therapy CDMO Product Market Performance
9.5.4 Exothera Business Overview
9.5.5 Exothera Recent Developments
9.6 WuXi AppTec
9.6.1 WuXi AppTec Cell Therapy CDMO Basic Information
9.6.2 WuXi AppTec Cell Therapy CDMO Product Overview
9.6.3 WuXi AppTec Cell Therapy CDMO Product Market Performance
9.6.4 WuXi AppTec Business Overview
9.6.5 WuXi AppTec Recent Developments
9.7 Pharmaron
9.7.1 Pharmaron Cell Therapy CDMO Basic Information
9.7.2 Pharmaron Cell Therapy CDMO Product Overview
9.7.3 Pharmaron Cell Therapy CDMO Product Market Performance
9.7.4 Pharmaron Business Overview
9.7.5 Pharmaron Recent Developments
9.8 OBiO
9.8.1 OBiO Cell Therapy CDMO Basic Information
9.8.2 OBiO Cell Therapy CDMO Product Overview
9.8.3 OBiO Cell Therapy CDMO Product Market Performance
9.8.4 OBiO Business Overview
9.8.5 OBiO Recent Developments
9.9 Cell Therapies
9.9.1 Cell Therapies Cell Therapy CDMO Basic Information
9.9.2 Cell Therapies Cell Therapy CDMO Product Overview
9.9.3 Cell Therapies Cell Therapy CDMO Product Market Performance
9.9.4 Cell Therapies Business Overview
9.9.5 Cell Therapies Recent Developments
9.10 AGC Biologics
9.10.1 AGC Biologics Cell Therapy CDMO Basic Information
9.10.2 AGC Biologics Cell Therapy CDMO Product Overview
9.10.3 AGC Biologics Cell Therapy CDMO Product Market Performance
9.10.4 AGC Biologics Business Overview
9.10.5 AGC Biologics Recent Developments
9.11 Cytiva
9.11.1 Cytiva Cell Therapy CDMO Basic Information
9.11.2 Cytiva Cell Therapy CDMO Product Overview
9.11.3 Cytiva Cell Therapy CDMO Product Market Performance
9.11.4 Cytiva Business Overview
9.11.5 Cytiva Recent Developments
9.12 Helixmith
9.12.1 Helixmith Cell Therapy CDMO Basic Information
9.12.2 Helixmith Cell Therapy CDMO Product Overview
9.12.3 Helixmith Cell Therapy CDMO Product Market Performance
9.12.4 Helixmith Business Overview
9.12.5 Helixmith Recent Developments
9.13 ThermoGenesis
9.13.1 ThermoGenesis Cell Therapy CDMO Basic Information
9.13.2 ThermoGenesis Cell Therapy CDMO Product Overview
9.13.3 ThermoGenesis Cell Therapy CDMO Product Market Performance
9.13.4 ThermoGenesis Business Overview
9.13.5 ThermoGenesis Recent Developments
9.14 Anemocyte
9.14.1 Anemocyte Cell Therapy CDMO Basic Information
9.14.2 Anemocyte Cell Therapy CDMO Product Overview
9.14.3 Anemocyte Cell Therapy CDMO Product Market Performance
9.14.4 Anemocyte Business Overview
9.14.5 Anemocyte Recent Developments
9.15 Thermo Fisher Scientific
9.15.1 Thermo Fisher Scientific Cell Therapy CDMO Basic Information
9.15.2 Thermo Fisher Scientific Cell Therapy CDMO Product Overview
9.15.3 Thermo Fisher Scientific Cell Therapy CDMO Product Market Performance
9.15.4 Thermo Fisher Scientific Business Overview
9.15.5 Thermo Fisher Scientific Recent Developments
9.16 CBM
9.16.1 CBM Cell Therapy CDMO Basic Information
9.16.2 CBM Cell Therapy CDMO Product Overview
9.16.3 CBM Cell Therapy CDMO Product Market Performance
9.16.4 CBM Business Overview
9.16.5 CBM Recent Developments
9.17 Bio Elpida
9.17.1 Bio Elpida Cell Therapy CDMO Basic Information
9.17.2 Bio Elpida Cell Therapy CDMO Product Overview
9.17.3 Bio Elpida Cell Therapy CDMO Product Market Performance
9.17.4 Bio Elpida Business Overview
9.17.5 Bio Elpida Recent Developments
9.18 Genezen
9.18.1 Genezen Cell Therapy CDMO Basic Information
9.18.2 Genezen Cell Therapy CDMO Product Overview
9.18.3 Genezen Cell Therapy CDMO Product Market Performance
9.18.4 Genezen Business Overview
9.18.5 Genezen Recent Developments
9.19 CCRM
9.19.1 CCRM Cell Therapy CDMO Basic Information
9.19.2 CCRM Cell Therapy CDMO Product Overview
9.19.3 CCRM Cell Therapy CDMO Product Market Performance
9.19.4 CCRM Business Overview
9.19.5 CCRM Recent Developments
9.20 RoslinCT
9.20.1 RoslinCT Cell Therapy CDMO Basic Information
9.20.2 RoslinCT Cell Therapy CDMO Product Overview
9.20.3 RoslinCT Cell Therapy CDMO Product Market Performance
9.20.4 RoslinCT Business Overview
9.20.5 RoslinCT Recent Developments
9.21 GenScript ProBio
9.21.1 GenScript ProBio Cell Therapy CDMO Basic Information
9.21.2 GenScript ProBio Cell Therapy CDMO Product Overview
9.21.3 GenScript ProBio Cell Therapy CDMO Product Market Performance
9.21.4 GenScript ProBio Business Overview
9.21.5 GenScript ProBio Recent Developments
10 CELL THERAPY CDMO REGIONAL MARKET FORECAST
10.1 Global Cell Therapy CDMO Market Size Forecast
10.2 Global Cell Therapy CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cell Therapy CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Cell Therapy CDMO Market Size Forecast by Region
10.2.4 South America Cell Therapy CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cell Therapy CDMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Cell Therapy CDMO Market Forecast by Type (2025-2030)
11.2 Global Cell Therapy CDMO Market Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cell Therapy CDMO
1.2 Key Market Segments
1.2.1 Cell Therapy CDMO Segment by Type
1.2.2 Cell Therapy CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL THERAPY CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL THERAPY CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Global Cell Therapy CDMO Revenue Market Share by Company (2019-2024)
3.2 Cell Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Cell Therapy CDMO Market Size Sites, Area Served, Product Type
3.4 Cell Therapy CDMO Market Competitive Situation and Trends
3.4.1 Cell Therapy CDMO Market Concentration Rate
3.4.2 Global 5 and 10 Largest Cell Therapy CDMO Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 CELL THERAPY CDMO VALUE CHAIN ANALYSIS
4.1 Cell Therapy CDMO Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL THERAPY CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 CELL THERAPY CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell Therapy CDMO Market Size Market Share by Type (2019-2024)
6.3 Global Cell Therapy CDMO Market Size Growth Rate by Type (2019-2024)
7 CELL THERAPY CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell Therapy CDMO Market Size (M USD) by Application (2019-2024)
7.3 Global Cell Therapy CDMO Market Size Growth Rate by Application (2019-2024)
8 CELL THERAPY CDMO MARKET SEGMENTATION BY REGION
8.1 Global Cell Therapy CDMO Market Size by Region
8.1.1 Global Cell Therapy CDMO Market Size by Region
8.1.2 Global Cell Therapy CDMO Market Size Market Share by Region
8.2 North America
8.2.1 North America Cell Therapy CDMO Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cell Therapy CDMO Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cell Therapy CDMO Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cell Therapy CDMO Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cell Therapy CDMO Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Charles River
9.1.1 Charles River Cell Therapy CDMO Basic Information
9.1.2 Charles River Cell Therapy CDMO Product Overview
9.1.3 Charles River Cell Therapy CDMO Product Market Performance
9.1.4 Charles River Cell Therapy CDMO SWOT Analysis
9.1.5 Charles River Business Overview
9.1.6 Charles River Recent Developments
9.2 The Discovery Labs
9.2.1 The Discovery Labs Cell Therapy CDMO Basic Information
9.2.2 The Discovery Labs Cell Therapy CDMO Product Overview
9.2.3 The Discovery Labs Cell Therapy CDMO Product Market Performance
9.2.4 The Discovery Labs Cell Therapy CDMO SWOT Analysis
9.2.5 The Discovery Labs Business Overview
9.2.6 The Discovery Labs Recent Developments
9.3 BIOCENTRIQ
9.3.1 BIOCENTRIQ Cell Therapy CDMO Basic Information
9.3.2 BIOCENTRIQ Cell Therapy CDMO Product Overview
9.3.3 BIOCENTRIQ Cell Therapy CDMO Product Market Performance
9.3.4 BIOCENTRIQ Cell Therapy CDMO SWOT Analysis
9.3.5 BIOCENTRIQ Business Overview
9.3.6 BIOCENTRIQ Recent Developments
9.4 FUJIFILM Diosynth Biotechnologies
9.4.1 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Basic Information
9.4.2 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product Overview
9.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product Market Performance
9.4.4 FUJIFILM Diosynth Biotechnologies Business Overview
9.4.5 FUJIFILM Diosynth Biotechnologies Recent Developments
9.5 Exothera
9.5.1 Exothera Cell Therapy CDMO Basic Information
9.5.2 Exothera Cell Therapy CDMO Product Overview
9.5.3 Exothera Cell Therapy CDMO Product Market Performance
9.5.4 Exothera Business Overview
9.5.5 Exothera Recent Developments
9.6 WuXi AppTec
9.6.1 WuXi AppTec Cell Therapy CDMO Basic Information
9.6.2 WuXi AppTec Cell Therapy CDMO Product Overview
9.6.3 WuXi AppTec Cell Therapy CDMO Product Market Performance
9.6.4 WuXi AppTec Business Overview
9.6.5 WuXi AppTec Recent Developments
9.7 Pharmaron
9.7.1 Pharmaron Cell Therapy CDMO Basic Information
9.7.2 Pharmaron Cell Therapy CDMO Product Overview
9.7.3 Pharmaron Cell Therapy CDMO Product Market Performance
9.7.4 Pharmaron Business Overview
9.7.5 Pharmaron Recent Developments
9.8 OBiO
9.8.1 OBiO Cell Therapy CDMO Basic Information
9.8.2 OBiO Cell Therapy CDMO Product Overview
9.8.3 OBiO Cell Therapy CDMO Product Market Performance
9.8.4 OBiO Business Overview
9.8.5 OBiO Recent Developments
9.9 Cell Therapies
9.9.1 Cell Therapies Cell Therapy CDMO Basic Information
9.9.2 Cell Therapies Cell Therapy CDMO Product Overview
9.9.3 Cell Therapies Cell Therapy CDMO Product Market Performance
9.9.4 Cell Therapies Business Overview
9.9.5 Cell Therapies Recent Developments
9.10 AGC Biologics
9.10.1 AGC Biologics Cell Therapy CDMO Basic Information
9.10.2 AGC Biologics Cell Therapy CDMO Product Overview
9.10.3 AGC Biologics Cell Therapy CDMO Product Market Performance
9.10.4 AGC Biologics Business Overview
9.10.5 AGC Biologics Recent Developments
9.11 Cytiva
9.11.1 Cytiva Cell Therapy CDMO Basic Information
9.11.2 Cytiva Cell Therapy CDMO Product Overview
9.11.3 Cytiva Cell Therapy CDMO Product Market Performance
9.11.4 Cytiva Business Overview
9.11.5 Cytiva Recent Developments
9.12 Helixmith
9.12.1 Helixmith Cell Therapy CDMO Basic Information
9.12.2 Helixmith Cell Therapy CDMO Product Overview
9.12.3 Helixmith Cell Therapy CDMO Product Market Performance
9.12.4 Helixmith Business Overview
9.12.5 Helixmith Recent Developments
9.13 ThermoGenesis
9.13.1 ThermoGenesis Cell Therapy CDMO Basic Information
9.13.2 ThermoGenesis Cell Therapy CDMO Product Overview
9.13.3 ThermoGenesis Cell Therapy CDMO Product Market Performance
9.13.4 ThermoGenesis Business Overview
9.13.5 ThermoGenesis Recent Developments
9.14 Anemocyte
9.14.1 Anemocyte Cell Therapy CDMO Basic Information
9.14.2 Anemocyte Cell Therapy CDMO Product Overview
9.14.3 Anemocyte Cell Therapy CDMO Product Market Performance
9.14.4 Anemocyte Business Overview
9.14.5 Anemocyte Recent Developments
9.15 Thermo Fisher Scientific
9.15.1 Thermo Fisher Scientific Cell Therapy CDMO Basic Information
9.15.2 Thermo Fisher Scientific Cell Therapy CDMO Product Overview
9.15.3 Thermo Fisher Scientific Cell Therapy CDMO Product Market Performance
9.15.4 Thermo Fisher Scientific Business Overview
9.15.5 Thermo Fisher Scientific Recent Developments
9.16 CBM
9.16.1 CBM Cell Therapy CDMO Basic Information
9.16.2 CBM Cell Therapy CDMO Product Overview
9.16.3 CBM Cell Therapy CDMO Product Market Performance
9.16.4 CBM Business Overview
9.16.5 CBM Recent Developments
9.17 Bio Elpida
9.17.1 Bio Elpida Cell Therapy CDMO Basic Information
9.17.2 Bio Elpida Cell Therapy CDMO Product Overview
9.17.3 Bio Elpida Cell Therapy CDMO Product Market Performance
9.17.4 Bio Elpida Business Overview
9.17.5 Bio Elpida Recent Developments
9.18 Genezen
9.18.1 Genezen Cell Therapy CDMO Basic Information
9.18.2 Genezen Cell Therapy CDMO Product Overview
9.18.3 Genezen Cell Therapy CDMO Product Market Performance
9.18.4 Genezen Business Overview
9.18.5 Genezen Recent Developments
9.19 CCRM
9.19.1 CCRM Cell Therapy CDMO Basic Information
9.19.2 CCRM Cell Therapy CDMO Product Overview
9.19.3 CCRM Cell Therapy CDMO Product Market Performance
9.19.4 CCRM Business Overview
9.19.5 CCRM Recent Developments
9.20 RoslinCT
9.20.1 RoslinCT Cell Therapy CDMO Basic Information
9.20.2 RoslinCT Cell Therapy CDMO Product Overview
9.20.3 RoslinCT Cell Therapy CDMO Product Market Performance
9.20.4 RoslinCT Business Overview
9.20.5 RoslinCT Recent Developments
9.21 GenScript ProBio
9.21.1 GenScript ProBio Cell Therapy CDMO Basic Information
9.21.2 GenScript ProBio Cell Therapy CDMO Product Overview
9.21.3 GenScript ProBio Cell Therapy CDMO Product Market Performance
9.21.4 GenScript ProBio Business Overview
9.21.5 GenScript ProBio Recent Developments
10 CELL THERAPY CDMO REGIONAL MARKET FORECAST
10.1 Global Cell Therapy CDMO Market Size Forecast
10.2 Global Cell Therapy CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cell Therapy CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Cell Therapy CDMO Market Size Forecast by Region
10.2.4 South America Cell Therapy CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cell Therapy CDMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Cell Therapy CDMO Market Forecast by Type (2025-2030)
11.2 Global Cell Therapy CDMO Market Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cell Therapy CDMO Market Size Comparison by Region (M USD)
Table 5. Global Cell Therapy CDMO Revenue (M USD) by Company (2019-2024)
Table 6. Global Cell Therapy CDMO Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy CDMO as of 2022)
Table 8. Company Cell Therapy CDMO Market Size Sites and Area Served
Table 9. Company Cell Therapy CDMO Product Type
Table 10. Global Cell Therapy CDMO Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Cell Therapy CDMO
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Cell Therapy CDMO Market Challenges
Table 18. Global Cell Therapy CDMO Market Size by Type (M USD)
Table 19. Global Cell Therapy CDMO Market Size (M USD) by Type (2019-2024)
Table 20. Global Cell Therapy CDMO Market Size Share by Type (2019-2024)
Table 21. Global Cell Therapy CDMO Market Size Growth Rate by Type (2019-2024)
Table 22. Global Cell Therapy CDMO Market Size by Application
Table 23. Global Cell Therapy CDMO Market Size by Application (2019-2024) & (M USD)
Table 24. Global Cell Therapy CDMO Market Share by Application (2019-2024)
Table 25. Global Cell Therapy CDMO Market Size Growth Rate by Application (2019-2024)
Table 26. Global Cell Therapy CDMO Market Size by Region (2019-2024) & (M USD)
Table 27. Global Cell Therapy CDMO Market Size Market Share by Region (2019-2024)
Table 28. North America Cell Therapy CDMO Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Cell Therapy CDMO Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Cell Therapy CDMO Market Size by Region (2019-2024) & (M USD)
Table 31. South America Cell Therapy CDMO Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Cell Therapy CDMO Market Size by Region (2019-2024) & (M USD)
Table 33. Charles River Cell Therapy CDMO Basic Information
Table 34. Charles River Cell Therapy CDMO Product Overview
Table 35. Charles River Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 36. Charles River Cell Therapy CDMO SWOT Analysis
Table 37. Charles River Business Overview
Table 38. Charles River Recent Developments
Table 39. The Discovery Labs Cell Therapy CDMO Basic Information
Table 40. The Discovery Labs Cell Therapy CDMO Product Overview
Table 41. The Discovery Labs Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 42. The Discovery Labs Cell Therapy CDMO SWOT Analysis
Table 43. The Discovery Labs Business Overview
Table 44. The Discovery Labs Recent Developments
Table 45. BIOCENTRIQ Cell Therapy CDMO Basic Information
Table 46. BIOCENTRIQ Cell Therapy CDMO Product Overview
Table 47. BIOCENTRIQ Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 48. BIOCENTRIQ Cell Therapy CDMO SWOT Analysis
Table 49. BIOCENTRIQ Business Overview
Table 50. BIOCENTRIQ Recent Developments
Table 51. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Basic Information
Table 52. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product Overview
Table 53. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 54. FUJIFILM Diosynth Biotechnologies Business Overview
Table 55. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 56. Exothera Cell Therapy CDMO Basic Information
Table 57. Exothera Cell Therapy CDMO Product Overview
Table 58. Exothera Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 59. Exothera Business Overview
Table 60. Exothera Recent Developments
Table 61. WuXi AppTec Cell Therapy CDMO Basic Information
Table 62. WuXi AppTec Cell Therapy CDMO Product Overview
Table 63. WuXi AppTec Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 64. WuXi AppTec Business Overview
Table 65. WuXi AppTec Recent Developments
Table 66. Pharmaron Cell Therapy CDMO Basic Information
Table 67. Pharmaron Cell Therapy CDMO Product Overview
Table 68. Pharmaron Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Pharmaron Business Overview
Table 70. Pharmaron Recent Developments
Table 71. OBiO Cell Therapy CDMO Basic Information
Table 72. OBiO Cell Therapy CDMO Product Overview
Table 73. OBiO Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 74. OBiO Business Overview
Table 75. OBiO Recent Developments
Table 76. Cell Therapies Cell Therapy CDMO Basic Information
Table 77. Cell Therapies Cell Therapy CDMO Product Overview
Table 78. Cell Therapies Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 79. Cell Therapies Business Overview
Table 80. Cell Therapies Recent Developments
Table 81. AGC Biologics Cell Therapy CDMO Basic Information
Table 82. AGC Biologics Cell Therapy CDMO Product Overview
Table 83. AGC Biologics Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 84. AGC Biologics Business Overview
Table 85. AGC Biologics Recent Developments
Table 86. Cytiva Cell Therapy CDMO Basic Information
Table 87. Cytiva Cell Therapy CDMO Product Overview
Table 88. Cytiva Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 89. Cytiva Business Overview
Table 90. Cytiva Recent Developments
Table 91. Helixmith Cell Therapy CDMO Basic Information
Table 92. Helixmith Cell Therapy CDMO Product Overview
Table 93. Helixmith Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 94. Helixmith Business Overview
Table 95. Helixmith Recent Developments
Table 96. ThermoGenesis Cell Therapy CDMO Basic Information
Table 97. ThermoGenesis Cell Therapy CDMO Product Overview
Table 98. ThermoGenesis Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 99. ThermoGenesis Business Overview
Table 100. ThermoGenesis Recent Developments
Table 101. Anemocyte Cell Therapy CDMO Basic Information
Table 102. Anemocyte Cell Therapy CDMO Product Overview
Table 103. Anemocyte Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 104. Anemocyte Business Overview
Table 105. Anemocyte Recent Developments
Table 106. Thermo Fisher Scientific Cell Therapy CDMO Basic Information
Table 107. Thermo Fisher Scientific Cell Therapy CDMO Product Overview
Table 108. Thermo Fisher Scientific Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 109. Thermo Fisher Scientific Business Overview
Table 110. Thermo Fisher Scientific Recent Developments
Table 111. CBM Cell Therapy CDMO Basic Information
Table 112. CBM Cell Therapy CDMO Product Overview
Table 113. CBM Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 114. CBM Business Overview
Table 115. CBM Recent Developments
Table 116. Bio Elpida Cell Therapy CDMO Basic Information
Table 117. Bio Elpida Cell Therapy CDMO Product Overview
Table 118. Bio Elpida Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 119. Bio Elpida Business Overview
Table 120. Bio Elpida Recent Developments
Table 121. Genezen Cell Therapy CDMO Basic Information
Table 122. Genezen Cell Therapy CDMO Product Overview
Table 123. Genezen Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 124. Genezen Business Overview
Table 125. Genezen Recent Developments
Table 126. CCRM Cell Therapy CDMO Basic Information
Table 127. CCRM Cell Therapy CDMO Product Overview
Table 128. CCRM Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 129. CCRM Business Overview
Table 130. CCRM Recent Developments
Table 131. RoslinCT Cell Therapy CDMO Basic Information
Table 132. RoslinCT Cell Therapy CDMO Product Overview
Table 133. RoslinCT Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 134. RoslinCT Business Overview
Table 135. RoslinCT Recent Developments
Table 136. GenScript ProBio Cell Therapy CDMO Basic Information
Table 137. GenScript ProBio Cell Therapy CDMO Product Overview
Table 138. GenScript ProBio Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 139. GenScript ProBio Business Overview
Table 140. GenScript ProBio Recent Developments
Table 141. Global Cell Therapy CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 142. North America Cell Therapy CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Europe Cell Therapy CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 144. Asia Pacific Cell Therapy CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 145. South America Cell Therapy CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Cell Therapy CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Global Cell Therapy CDMO Market Size Forecast by Type (2025-2030) & (M USD)
Table 148. Global Cell Therapy CDMO Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cell Therapy CDMO Market Size Comparison by Region (M USD)
Table 5. Global Cell Therapy CDMO Revenue (M USD) by Company (2019-2024)
Table 6. Global Cell Therapy CDMO Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy CDMO as of 2022)
Table 8. Company Cell Therapy CDMO Market Size Sites and Area Served
Table 9. Company Cell Therapy CDMO Product Type
Table 10. Global Cell Therapy CDMO Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Cell Therapy CDMO
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Cell Therapy CDMO Market Challenges
Table 18. Global Cell Therapy CDMO Market Size by Type (M USD)
Table 19. Global Cell Therapy CDMO Market Size (M USD) by Type (2019-2024)
Table 20. Global Cell Therapy CDMO Market Size Share by Type (2019-2024)
Table 21. Global Cell Therapy CDMO Market Size Growth Rate by Type (2019-2024)
Table 22. Global Cell Therapy CDMO Market Size by Application
Table 23. Global Cell Therapy CDMO Market Size by Application (2019-2024) & (M USD)
Table 24. Global Cell Therapy CDMO Market Share by Application (2019-2024)
Table 25. Global Cell Therapy CDMO Market Size Growth Rate by Application (2019-2024)
Table 26. Global Cell Therapy CDMO Market Size by Region (2019-2024) & (M USD)
Table 27. Global Cell Therapy CDMO Market Size Market Share by Region (2019-2024)
Table 28. North America Cell Therapy CDMO Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Cell Therapy CDMO Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Cell Therapy CDMO Market Size by Region (2019-2024) & (M USD)
Table 31. South America Cell Therapy CDMO Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Cell Therapy CDMO Market Size by Region (2019-2024) & (M USD)
Table 33. Charles River Cell Therapy CDMO Basic Information
Table 34. Charles River Cell Therapy CDMO Product Overview
Table 35. Charles River Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 36. Charles River Cell Therapy CDMO SWOT Analysis
Table 37. Charles River Business Overview
Table 38. Charles River Recent Developments
Table 39. The Discovery Labs Cell Therapy CDMO Basic Information
Table 40. The Discovery Labs Cell Therapy CDMO Product Overview
Table 41. The Discovery Labs Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 42. The Discovery Labs Cell Therapy CDMO SWOT Analysis
Table 43. The Discovery Labs Business Overview
Table 44. The Discovery Labs Recent Developments
Table 45. BIOCENTRIQ Cell Therapy CDMO Basic Information
Table 46. BIOCENTRIQ Cell Therapy CDMO Product Overview
Table 47. BIOCENTRIQ Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 48. BIOCENTRIQ Cell Therapy CDMO SWOT Analysis
Table 49. BIOCENTRIQ Business Overview
Table 50. BIOCENTRIQ Recent Developments
Table 51. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Basic Information
Table 52. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product Overview
Table 53. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 54. FUJIFILM Diosynth Biotechnologies Business Overview
Table 55. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 56. Exothera Cell Therapy CDMO Basic Information
Table 57. Exothera Cell Therapy CDMO Product Overview
Table 58. Exothera Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 59. Exothera Business Overview
Table 60. Exothera Recent Developments
Table 61. WuXi AppTec Cell Therapy CDMO Basic Information
Table 62. WuXi AppTec Cell Therapy CDMO Product Overview
Table 63. WuXi AppTec Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 64. WuXi AppTec Business Overview
Table 65. WuXi AppTec Recent Developments
Table 66. Pharmaron Cell Therapy CDMO Basic Information
Table 67. Pharmaron Cell Therapy CDMO Product Overview
Table 68. Pharmaron Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Pharmaron Business Overview
Table 70. Pharmaron Recent Developments
Table 71. OBiO Cell Therapy CDMO Basic Information
Table 72. OBiO Cell Therapy CDMO Product Overview
Table 73. OBiO Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 74. OBiO Business Overview
Table 75. OBiO Recent Developments
Table 76. Cell Therapies Cell Therapy CDMO Basic Information
Table 77. Cell Therapies Cell Therapy CDMO Product Overview
Table 78. Cell Therapies Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 79. Cell Therapies Business Overview
Table 80. Cell Therapies Recent Developments
Table 81. AGC Biologics Cell Therapy CDMO Basic Information
Table 82. AGC Biologics Cell Therapy CDMO Product Overview
Table 83. AGC Biologics Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 84. AGC Biologics Business Overview
Table 85. AGC Biologics Recent Developments
Table 86. Cytiva Cell Therapy CDMO Basic Information
Table 87. Cytiva Cell Therapy CDMO Product Overview
Table 88. Cytiva Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 89. Cytiva Business Overview
Table 90. Cytiva Recent Developments
Table 91. Helixmith Cell Therapy CDMO Basic Information
Table 92. Helixmith Cell Therapy CDMO Product Overview
Table 93. Helixmith Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 94. Helixmith Business Overview
Table 95. Helixmith Recent Developments
Table 96. ThermoGenesis Cell Therapy CDMO Basic Information
Table 97. ThermoGenesis Cell Therapy CDMO Product Overview
Table 98. ThermoGenesis Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 99. ThermoGenesis Business Overview
Table 100. ThermoGenesis Recent Developments
Table 101. Anemocyte Cell Therapy CDMO Basic Information
Table 102. Anemocyte Cell Therapy CDMO Product Overview
Table 103. Anemocyte Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 104. Anemocyte Business Overview
Table 105. Anemocyte Recent Developments
Table 106. Thermo Fisher Scientific Cell Therapy CDMO Basic Information
Table 107. Thermo Fisher Scientific Cell Therapy CDMO Product Overview
Table 108. Thermo Fisher Scientific Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 109. Thermo Fisher Scientific Business Overview
Table 110. Thermo Fisher Scientific Recent Developments
Table 111. CBM Cell Therapy CDMO Basic Information
Table 112. CBM Cell Therapy CDMO Product Overview
Table 113. CBM Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 114. CBM Business Overview
Table 115. CBM Recent Developments
Table 116. Bio Elpida Cell Therapy CDMO Basic Information
Table 117. Bio Elpida Cell Therapy CDMO Product Overview
Table 118. Bio Elpida Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 119. Bio Elpida Business Overview
Table 120. Bio Elpida Recent Developments
Table 121. Genezen Cell Therapy CDMO Basic Information
Table 122. Genezen Cell Therapy CDMO Product Overview
Table 123. Genezen Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 124. Genezen Business Overview
Table 125. Genezen Recent Developments
Table 126. CCRM Cell Therapy CDMO Basic Information
Table 127. CCRM Cell Therapy CDMO Product Overview
Table 128. CCRM Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 129. CCRM Business Overview
Table 130. CCRM Recent Developments
Table 131. RoslinCT Cell Therapy CDMO Basic Information
Table 132. RoslinCT Cell Therapy CDMO Product Overview
Table 133. RoslinCT Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 134. RoslinCT Business Overview
Table 135. RoslinCT Recent Developments
Table 136. GenScript ProBio Cell Therapy CDMO Basic Information
Table 137. GenScript ProBio Cell Therapy CDMO Product Overview
Table 138. GenScript ProBio Cell Therapy CDMO Revenue (M USD) and Gross Margin (2019-2024)
Table 139. GenScript ProBio Business Overview
Table 140. GenScript ProBio Recent Developments
Table 141. Global Cell Therapy CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 142. North America Cell Therapy CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Europe Cell Therapy CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 144. Asia Pacific Cell Therapy CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 145. South America Cell Therapy CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Cell Therapy CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Global Cell Therapy CDMO Market Size Forecast by Type (2025-2030) & (M USD)
Table 148. Global Cell Therapy CDMO Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Industrial Chain of Cell Therapy CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell Therapy CDMO Market Size (M USD), 2019-2030
Figure 5. Global Cell Therapy CDMO Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Cell Therapy CDMO Market Size by Country (M USD)
Figure 10. Global Cell Therapy CDMO Revenue Share by Company in 2023
Figure 11. Cell Therapy CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Cell Therapy CDMO Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Cell Therapy CDMO Market Share by Type
Figure 15. Market Size Share of Cell Therapy CDMO by Type (2019-2024)
Figure 16. Market Size Market Share of Cell Therapy CDMO by Type in 2022
Figure 17. Global Cell Therapy CDMO Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Cell Therapy CDMO Market Share by Application
Figure 20. Global Cell Therapy CDMO Market Share by Application (2019-2024)
Figure 21. Global Cell Therapy CDMO Market Share by Application in 2022
Figure 22. Global Cell Therapy CDMO Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Cell Therapy CDMO Market Size Market Share by Region (2019-2024)
Figure 24. North America Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Cell Therapy CDMO Market Size Market Share by Country in 2023
Figure 26. U.S. Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Cell Therapy CDMO Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Cell Therapy CDMO Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Cell Therapy CDMO Market Size Market Share by Country in 2023
Figure 31. Germany Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Cell Therapy CDMO Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Cell Therapy CDMO Market Size Market Share by Region in 2023
Figure 38. China Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Cell Therapy CDMO Market Size and Growth Rate (M USD)
Figure 44. South America Cell Therapy CDMO Market Size Market Share by Country in 2023
Figure 45. Brazil Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Cell Therapy CDMO Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Cell Therapy CDMO Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Cell Therapy CDMO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Cell Therapy CDMO Market Share Forecast by Type (2025-2030)
Figure 57. Global Cell Therapy CDMO Market Share Forecast by Application (2025-2030)
Figure 1. Industrial Chain of Cell Therapy CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell Therapy CDMO Market Size (M USD), 2019-2030
Figure 5. Global Cell Therapy CDMO Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Cell Therapy CDMO Market Size by Country (M USD)
Figure 10. Global Cell Therapy CDMO Revenue Share by Company in 2023
Figure 11. Cell Therapy CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Cell Therapy CDMO Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Cell Therapy CDMO Market Share by Type
Figure 15. Market Size Share of Cell Therapy CDMO by Type (2019-2024)
Figure 16. Market Size Market Share of Cell Therapy CDMO by Type in 2022
Figure 17. Global Cell Therapy CDMO Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Cell Therapy CDMO Market Share by Application
Figure 20. Global Cell Therapy CDMO Market Share by Application (2019-2024)
Figure 21. Global Cell Therapy CDMO Market Share by Application in 2022
Figure 22. Global Cell Therapy CDMO Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Cell Therapy CDMO Market Size Market Share by Region (2019-2024)
Figure 24. North America Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Cell Therapy CDMO Market Size Market Share by Country in 2023
Figure 26. U.S. Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Cell Therapy CDMO Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Cell Therapy CDMO Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Cell Therapy CDMO Market Size Market Share by Country in 2023
Figure 31. Germany Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Cell Therapy CDMO Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Cell Therapy CDMO Market Size Market Share by Region in 2023
Figure 38. China Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Cell Therapy CDMO Market Size and Growth Rate (M USD)
Figure 44. South America Cell Therapy CDMO Market Size Market Share by Country in 2023
Figure 45. Brazil Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Cell Therapy CDMO Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Cell Therapy CDMO Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Cell Therapy CDMO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Cell Therapy CDMO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Cell Therapy CDMO Market Share Forecast by Type (2025-2030)
Figure 57. Global Cell Therapy CDMO Market Share Forecast by Application (2025-2030)
